InvestorsHub Logo
Followers 21
Posts 327
Boards Moderated 1
Alias Born 02/06/2013

Re: hawkstar post# 19137

Saturday, 01/11/2014 10:15:19 PM

Saturday, January 11, 2014 10:15:19 PM

Post# of 182940
France Legalizes Marijuana-Based Drug To Treat Multiple Sclerosis

GWPH
http://www.huffingtonpost.com/2014/01/10/france-marijuana-based-drug-legalizes-multiple-sclerosis_n_4575780.html

PARIS (AP) — The French drug safety agency has approved commercial sales of a medicine derived from cannabis for the first time in France.

France's Health Ministry said in a statement Wednesday that sales of Sativex, produced by Britain's GW Pharmaceuticals, will be allowed for the treatment of muscle spasms associated with multiple sclerosis.

Sativex contains marijuana's two best known components — delta 9-THC and cannabidiol. The company's website says the medicine has already been launched in 11 countries and approved in more than a dozen others.

A number of countries have been easing curbs on the sale of cannabis-based products for medical use in recent years, and the U.S. state of Colorado allowed the nation's first legal recreational marijuana shops to open starting this year.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.